v3 Template
T

Traws Pharma, Inc.

Biopharmaceutical NEWTOWN, Pa., USA ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$72.6M
Funding Rounds
1
Last Funding
2024-12-30

About Traws Pharma, Inc.

Traws Pharma is a clinical stage biopharmaceutical company focused on developing novel therapies to address critical threats to human health, particularly in respiratory viral diseases. The company is committed to advancing investigational antiviral agents with potent activity against resistant virus strains, aiming for safe treatments with simple dosing regimens and accelerated clinical trial strategies, especially for vulnerable patients.

Products & Services

Tivoxavir marboxil:An investigational oral small molecule in development as a single dose treatment for bird flu and seasonal influenza, targeting the influenza cap-dependent endonuclease (CEN).
Ratutrelvir:An investigational oral small molecule in development as a treatment for COVID-19, targeting the Main protease (Mpro or 3CL protease), without the need for co-administration of ritonavir.

Specialties

Respiratory viral diseases Antiviral therapies Influenza treatment COVID-19 treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity Financing
T: -
FT: Equity Financing 		A: 72600000
MR: -
FA: up to $72.6 Million
FAN: 72600000 		D: 2024-12-30
FD: 2024-12-30 		5 investors
Equity Financing Latest
2024-12-30
$72.6M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jack E. Stover

Director

I

Iain Dukes

Chairman, Interim CEO, Director

W

Werner Cautreels

Chief Executive Officer

N

Nikolay Savchuk

Director & COO

T

Trafford Clarke

Director

T

Teresa Shoemaker

Director

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Traws Pharma, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~220 employees (est.)
Locations
NEWTOWN, Pa., USA
Newtown, Pa.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro